This is a preview of subscription content, log in via an institution to check access.
References
Abifadel M., Jambart S., Rabes J. P., Varret M., Allard D., Derre A. et al. 2004 Identification of the first Lebanese mutation in the LPL gene and description of a rapid detection method. Clin. Genet. 65, 158–161.
Abifadel M., Varret M., Rabes J. P., Allard D., Ouguerram K., Devillers M. et al. 2003 Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34, 154–156.
Beutler E., Gelbart T. and West C. 1990 The facile detection of the nt1226 mutation of glucocerebrosidase by mismatched PCR. Clin. Chim. Acta 194, 161–166.
Brustolin D., Maierna M., Aguzzi F., Zoppi F., Tarenghi G. and Berti G. 1991 Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B. Clin. Chem. 37, 742–747.
Chater R., Rabes J. P., Ait Chihab K., Varret M., Loutfi M., Ee Jahiri Y. et al. 2006 Mutational heterogeneity in low-density lipoprotein receptor gene related to familial hypercholestrolemia in Morocco clin. clin. Acta. 373, 62–69.
Civeira F. 2004 International panel on management of familial hypercholesterolemia: guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173, 55–68.
de Sauvage Nolting P. R. W., Defesche J. C., Buirma R. J. A., Hutten B. A., Lansberg P. J. and Kastelein J. J. P. 2003 Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolemia. J. Intern. Med. 253, 161–168.
El Messal M., Ait Chihab K., Chater R., Vallve J. C., Bennis F., Hafidi A. et al. 2003 Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene. J. Hum. Genet. 48, 199–203.
El Messal M., Ait Chihab K., Chater R., Kettani A., Hafidi A., Adlouni A. 2006 Which management of familial hypercholesterolemia in Morocco? Acta. Cardiologica 61(5), 551–555
Frénais R., Ouguerram K., Maugeais C., Marchini J. S., Benlian P., Bard J. M. et al. 1999 Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study. J. Lipid Res. 40, 1506–1511.
Friedewald W. T., Levy R. I. and Fredrickson D. S. 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502.
Guérin M., Dolphin P. J. and Chapman M. J. 1994 Preferential cholesteryl ester acceptors among the LDL subspecies of subjects with familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 14, 679–685.
Hixon J. E. and Vernier D. I. 1990 Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31, 545–548.
Miller S. A., Dykes D. D. and Polesky H. F. 1988 A simple salting out procedure for extracting DNA from nucleated cells. Nuclic Acids Res. 16, 1215.
Pimstone S. N., Gagne S. E., Gagne C., Lupien P. J., Gaudet D., Williams R. R. et al. 1995 Mutations in the gene for lipoprotein lipase: a cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 15, 1704–1712.
Pocovi M., Cenarro A., Civeira F., Torralba A., Perez-Calvo J. I., Mozas P. et al. 1998 Beta-glucocerebrosidase gene locus as a link for Gaucher’s disease and familial hypo-alpha-lipoproteinaemia. Lancet 351, 1903–1904.
Rabès J. P., Varret M., Saint-Jore B., Erlich D., Jondeau G., Giraudet P. et al. 1997 Familial ligand-defective apolipoprotein B-100: simultaneous detection of the Arg3500→Gln and Arg3531→Cys mutations in a French population. Hum. Mut. 10, 160–163.
Recalde D., Cenarro A., Garcia-Otin A. L., Gomez-Coronado D., Civeira F., Pocovi M. 2002 Analysis of apolipoprotein A-I, lecithin:cholesterol acyltransferase and glucocerebrosidase genes in hypoalphalipoproteinemia. Atherosclerosis 63, 49–58.
Sass C., Giroux L. M., Ma Y., Roy M., Lavigne J., Lussier-Cacan S. et al. 1995 Evidence for a cholesterol-lowering gene in a French-Canadian kindred with familial hypercholesterolemia. Hum. Genet. 96, 21–26.
Soria L. F., Ludwig E. H., Clarke H. R. G., Vega G. L., Grundy S. M., McCarty B. J. et al. 1989 Association between a specific apoB mutation and familial defective apo B 100. Proc. Natl. Acad. Sci. USA 86, 587–591.
Sun X. M., Patel D. D., Webb J. C., Knight B. L., Fan L. M., Cai H. J., Soutar A. K. et al. 1994 Familial hypercholesterolemia in China: identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arterioscler. Thromb. Vasc. Biol. 14, 85–94.
Tsuji S., Choudary P. V., Martin B. M., Stubblefield B. K., Mayor J. A., Barranger J. A. and Ginns E. I. 1987 A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher’s disease. New Engl. J. Med. 316, 570–575.
Wang N., Arai T., Ji Y., Rinninger F. and Tall A. R. 1998 Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J. Biol. Chem. 273, 32920–32926.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ait Chihab, K., Chater, R., Cenarro, A. et al. Familial hypercholesterolemia associated with severe hypoalphalipoproteinemia in a Moroccan family. J Genet 86, 159–163 (2007). https://doi.org/10.1007/s12041-007-0020-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-007-0020-0